Wearable sensor
Latest Biolinq Incorporated Patents:
- Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure
- Sensor assembly of a microneedle array-based continuous analyte monitoring device
- Microneedle array sensor applicator device
- Wearable sensor
- Wearable sensor with illuminated display
The broken lines are for the purpose of illustrating portions of the article and form no part of the claimed design.
Claims
The ornamental design for a wearable sensor, as shown and described.
4305401 | December 15, 1981 | Reissmueller et al. |
4323996 | April 6, 1982 | Ganter |
4407295 | October 4, 1983 | Steuer et al. |
5131390 | July 21, 1992 | Sakaguchi |
5279543 | January 18, 1994 | Glikfeld et al. |
5286364 | February 15, 1994 | Yacynych et al. |
5540828 | July 30, 1996 | Yacynych |
5730714 | March 24, 1998 | Guy et al. |
5766132 | June 16, 1998 | Yasukawa et al. |
6036055 | March 14, 2000 | Mogadam et al. |
6139718 | October 31, 2000 | Kurnik et al. |
6269053 | July 31, 2001 | Kawata et al. |
6284126 | September 4, 2001 | Kurnik et al. |
6413396 | July 2, 2002 | Yang et al. |
6471903 | October 29, 2002 | Sherman et al. |
6603987 | August 5, 2003 | Whitson |
6814845 | November 9, 2004 | Wilson et al. |
6862466 | March 1, 2005 | Ackerman |
6908453 | June 21, 2005 | Fleming |
7097776 | August 29, 2006 | Govinda Raju |
7132054 | November 7, 2006 | Kravitz et al. |
7262068 | August 28, 2007 | Roy et al. |
7343188 | March 11, 2008 | Sohrab |
7344499 | March 18, 2008 | Prausnitz et al. |
7429333 | September 30, 2008 | Chiou et al. |
7456112 | November 25, 2008 | Lee |
7493232 | February 17, 2009 | Surina |
8022292 | September 20, 2011 | Arianpour et al. |
8088321 | January 3, 2012 | Ferguson et al. |
8094009 | January 10, 2012 | Allen et al. |
8125331 | February 28, 2012 | Allen et al. |
8130095 | March 6, 2012 | Allen et al. |
8284046 | October 9, 2012 | Allen et al. |
8574165 | November 5, 2013 | Marsh |
8798799 | August 5, 2014 | Deo et al. |
8909543 | December 9, 2014 | Tropper et al. |
D722697 | February 17, 2015 | Moon et al. |
D750786 | March 1, 2016 | Davies et al. |
D757000 | May 24, 2016 | Lagomarsino et al. |
9551698 | January 24, 2017 | Huys et al. |
9737247 | August 22, 2017 | Wang et al. |
9743870 | August 29, 2017 | Wang et al. |
D815289 | April 10, 2018 | Evers et al. |
D816229 | April 24, 2018 | Frick et al. |
9933387 | April 3, 2018 | McCanna et al. |
D820988 | June 19, 2018 | Pushpala |
10092207 | October 9, 2018 | Windmiller |
10136846 | November 27, 2018 | Wang et al. |
D842996 | March 12, 2019 | Frick et al. |
D845289 | April 9, 2019 | Chuang |
10251565 | April 9, 2019 | Chan |
D867911 | November 26, 2019 | Alabdin |
10492708 | December 3, 2019 | Windmiller |
D875254 | February 11, 2020 | Cooke |
D882432 | April 28, 2020 | Yee |
10765369 | September 8, 2020 | Antonio |
11045142 | June 29, 2021 | Windmiller et al. |
11207025 | December 28, 2021 | Trapero Martin |
11406818 | August 9, 2022 | Windmiller |
11654270 | May 23, 2023 | Mansfield et al. |
11660392 | May 30, 2023 | Kamen |
20030225360 | December 4, 2003 | Eppstein |
20060015061 | January 19, 2006 | Kuo et al. |
20070170054 | July 26, 2007 | Wilsey |
20070213044 | September 13, 2007 | Steingart et al. |
20090088652 | April 2, 2009 | Tremblay |
20090143761 | June 4, 2009 | Cantor |
20090259118 | October 15, 2009 | Feldman et al. |
20100056873 | March 4, 2010 | Allen et al. |
20100286803 | November 11, 2010 | Tillotson et al. |
20120323097 | December 20, 2012 | Chowdhury |
20130065257 | March 14, 2013 | Wang et al. |
20130144131 | June 6, 2013 | Wang et al. |
20140259652 | September 18, 2014 | Pushpala et al. |
20140275897 | September 18, 2014 | Pushpala |
20140336487 | November 13, 2014 | Wang et al. |
20150335272 | November 26, 2015 | Natale et al. |
20170055851 | March 2, 2017 | Al-Ali |
20180249937 | September 6, 2018 | Wiese et al. |
20190095602 | March 28, 2019 | Setlak et al. |
20190125223 | May 2, 2019 | Wang et al. |
20190167167 | June 6, 2019 | Mitchell et al. |
20190309433 | October 10, 2019 | Sattayasamitsathit et al. |
20200085341 | March 19, 2020 | Windmiller |
20200101286 | April 2, 2020 | Windmiller et al. |
20200214566 | July 9, 2020 | Allen et al. |
20200254240 | August 13, 2020 | Windmiller et al. |
20200297997 | September 24, 2020 | Windmiller et al. |
20210187286 | June 24, 2021 | Windmiller et al. |
20210393201 | December 23, 2021 | Morelock et al. |
20220031209 | February 3, 2022 | Windmiller et al. |
20220031244 | February 3, 2022 | Windmiller et al. |
20220175278 | June 9, 2022 | Campbell et al. |
20220370011 | November 24, 2022 | Windmiller et al. |
20230074798 | March 9, 2023 | Tangney |
20230094419 | March 30, 2023 | Mansfield, III et al. |
20230099617 | March 30, 2023 | Mansfield, III et al. |
20230137258 | May 4, 2023 | Windmiller |
717520 | December 2021 | CH |
3871602 | September 2021 | EP |
3042872 | December 2020 | FR |
1721016 | July 2022 | JP |
WO-2009034313 | March 2009 | WO |
WO-2009064164 | May 2009 | WO |
WO-2010120364 | October 2010 | WO |
WO-2012020332 | February 2012 | WO |
WO-2013058879 | April 2013 | WO |
WO-2020073060 | April 2020 | WO |
WO-2021148596 | July 2021 | WO |
WO-2023055755 | April 2023 | WO |
WO-2023064877 | April 2023 | WO |
- Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
- American Diabetes Association® Press Release (2020). “American Diabetes Association ® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
- Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
- Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
- Biolinq, Inc. (2019). The Intelligent Continuous Glucose Monitoring System, 5 total pages.
- Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
- Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
- Dexcom (2020). Analyst Day Presentation, 19 total pages.
- Dexcom (2020). Analyst Day Presentation, 27 total pages.
- Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
- Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
- French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
- Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
- Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. Sci. Tech. 12:1211-1219.
- Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
- Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin—Treated Diabetes,” JAMA 325:2273-2284.
- Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin A Randomized Clinical Trial,” JAMA 325:2262-2272.
- McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
- Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Biomed. Optics 9:274-281.
- Non-Final Office Action dated Nov. 14, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
- Notice of Allowance dated Sep. 29, 2022, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 7 pages.
- Notice of Allowance dated Jan. 25, 2023, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 11 pages.
- Notice of Allowance dated Dec. 18, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 7 pages.
- Notice of Allowance dated May 17, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
- Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
- Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
- Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
- Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
- Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. doi: 10.7759/cureus.11195.
- Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
- Barrett et al., “Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
- Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
- Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
- Ehrhardt et al, “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
- Ehrhardt et al, “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring ” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
- Ehrhardt et al, “Continuous Glucose Monitoring As a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
- Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
- Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
- Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
- Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
- Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
- Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
- Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
- World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
- Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
Type: Grant
Filed: Nov 16, 2021
Date of Patent: Aug 29, 2023
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Michael Morelock (Escondido, CA)
Primary Examiner: Antoine Duval Davis
Application Number: 29/815,797